Akihisa Hanatani

Akihisa Hanatani

Auto-generated profile, based on publicly available information

Akihisa Hanatani

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2016 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
AHAkihisa Hanatani
Akihisa Hanatani
ASAtsushi Shibata
Atsushi Shibata
RKRyouko Kitada
Ryouko Kitada
SIShinichi Iwata
Shinichi Iwata
YMYoshiki Matsumura
Yoshiki Matsumura
MYMinoru Yoshiyama
Minoru Yoshiyama

26 April 2018 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
ASAtsushi Shibata
Atsushi Shibata
AHAkihisa Hanatani
Akihisa Hanatani
YIYasukatsu Izumi
Yasukatsu Izumi
RKRyoko Kitada
Ryoko Kitada
SIShinichi Iwata
Shinichi Iwata
MYMinoru Yoshiyama
Minoru Yoshiyama

1 January 2010 in Internal Medicine
Verified
Journal Article
Open access
PDF file
NONoboru Oda
Noboru Oda
TKTomoko S. Kato
Tomoko S. Kato
AHAkihisa Hanatani
Akihisa Hanatani
KNKazuo Niwaya
Kazuo Niwaya
TNTakeshi Nakatani
Takeshi Nakatani
KKKazuo Komamura
Kazuo Komamura
Reversible posterior leukoencephalopathy syndrome (RPLS) is one of the important adverse events following organ transplantation, associated with calcineurin inhibitors (CNIs). We describe a case of 54-year-old woman, who was diagnosed with RPLS within weeks after transplantation. Considering the risk of causing fatal rejection by discontinuation of CNIs, the immunosuppressive regimen of the patient was switched from a cyclosporine A-based regimen to a tacrolimus-based regimen. The patient recovered rapidly from RPLS following the switch to tacrolimus. This case demonstrated that not only discontinuation but also a substitution of CNIs would be a valid treatment option for RPLS in transplant recipients.

1 January 1998 in Japanese Circulation Journal
Verified
Journal Article
Closed access
MYMinoru Yoshiyama
Minoru Yoshiyama
KTKazuhide Takeuchi
Kazuhide Takeuchi
SKShokei Kim
Shokei Kim
AHAkihisa Hanatani
Akihisa Hanatani
TOTakashi Omura
Takashi Omura
JYJunichi Yoshikawa
Junichi Yoshikawa
We examined the effect of a calcium antagonist, manidipine hydrochloride, on cardiac hypertrophy and the expression of the atrial natriuretic peptide (ANP), transforming growth factor beta 1 (TGF-beta 1), and extracellular matrix protein genes in rats with isoproterenol-induced cardiac hypertrophy. Rats were continuously infused with saline or isoproterenol (0.5 mg/kg per day) for 7 days using an osmotic minipump. Treatment with manidipine hydrochloride (once a day at 3 mg/kg) began 1 day before minipump implantation and continued until the end of the experiments (each group; n = 6). After treatment, left ventricular weight was measured and mRNA was extracted and analyzed by Northern blot hybridization. Isoproterenol increased left ventricular weight (2.40 +/- 0.04 g/kg; p < 0.01) without increasing blood pressure. ANP, collagen type I and type III, and fibronectin mRNAs were increased 1.5-(p < 0.01), 1.9- (p < 0.01), 2.7- (p < 0.01), and 3.2-fold (p < 0.01), respectively, by isoproterenol infusion. However, TGF-beta 1, collagen type IV, and laminin B1 and B2 mRNA levels were unchanged by isoproterenol. Manidipine hydrochloride prevented isoproterenol-induced left ventricular hypertrophy (2.26 +/- 0.02 g/kg; p < 0.01) and expression of mRNA of ANP (0.9-fold of the control value; p < 0.01), collagen types I (1.1-fold; p < 0.01) and type III (1.6-fold; p < 0.01), and fibronectin (1.1-fold; p < 0.01). Thus, manidipine hydrochloride prevented cardiac hypertrophy and changes in the expression of genes for ANP and interstitial components of extracellular matrix induced by isoproterenol.

28 May 2013 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
PDF file
AIAsahiro Ito
Asahiro Ito
KSKenichi Sugioka
Kenichi Sugioka
YMYoshiki Matsumura
Yoshiki Matsumura
SFSuwako Fujita
Suwako Fujita
SIShinichi Iwata
Shinichi Iwata
MYMinoru Yoshiyama
Minoru Yoshiyama

1 January 1998 in Japanese Heart Journal
Verified
Journal Article
Open access
AHAkihisa Hanatani
Akihisa Hanatani
MYMinoru Yoshiyama
Minoru Yoshiyama
SKShokei Kim
Shokei Kim
TOTakashi Omura
Takashi Omura
YIYoshiyasu Ikuno
Yoshiyasu Ikuno
JYJunichi Yoshikawa
Junichi Yoshikawa
The purpose of this study was to examine left ventricular function and cardiac gene expressions at an acute phase after myocardial infarction (MI). MI was induced in rats by ligation of the left coronary artery. Two days after MI, we performed Doppler-echocardiography and measured the systolic and diastolic function. We then analyzed the contractile protein and extracellular matrix mRNAs of cardiac tissues in the infarcted region, including the adjacent noninfarcted myocardium (the adjacent noninfarcted myocardium) and the remote noninfarcted myocardium, by Northern blot hybridization. Fractional shortening decreased significantly to 28%. Peak early diastolic filling wave (E wave) velocity increased in MI rats (MI; 90 +/- 3 cm/s versus the control; 71 +/- 2 cm/s, p < 0.05), and the deceleration rate of the E wave velocity was more rapid in MI rats (MI; 22.0 +/- 2.6 m/s2 versus the control; 16.5 +/- 2.0 m/s2, p < 0.01). Atrial filling wave (A wave) velocity decreased, resulting in a marked increase in the ratio of E wave to A wave velocity (MI; 3.1 +/- 0.3 versus the control; 2.1 +/- 0.2, p < 0.01). In the adjacent noninfarcted myocardium, mRNA levels for alpha-skeletal actin, atrial natriuretic polypeptide (ANP), transforming growth factor-beta 1(TGF-beta 1), fibronectin, and collagen types I and III increased significantly. In the remote noninfarcted myocardium, mRNA levels for alpha-skeletal actin, ANP, and collagen types I and III increased, while mRNA levels for beta-myosin heavy chain, TGF-beta 1 and fibronectin did not change. We observed left ventricular dysfunction and different gene expression between adjacent noninfarcted myocardium and in the remote noninfarcted myocardium two days after MI. These findings suggest that cardiac gene expression after MI may be a compensation reaction for cardiac dysfunction induced by myocardial damage.